Literature DB >> 11749972

Biochemical and structural studies of the prion protein polymorphism.

C Petchanikow1, G P Saborio, L Anderes, M J Frossard, M I Olmedo, C Soto.   

Abstract

A hallmark event in transmissible spongiform encephalopathies is the conversion of the physiological prion protein into the disease-associated isoform. A natural polymorphism at codon 129 of the human prion gene, resulting in either methionine or valine, has profound influence on susceptibility and phenotypic expression of the disease in humans. In this study, we investigated the local propensity of synthetic peptides, corresponding to the region of the polymorphism and containing either methionine or valine, to adopt a beta-sheet-rich structure similar to the pathological protein. Circular dichroism studies showed that the methionine-containing peptide has a greater propensity to adopt a beta-sheet conformation in a variety of experimental conditions. The higher beta-sheet tendency of this peptide was also associated with an increased ability to aggregate into amyloid-like fibrils. These results suggest that methionine at position 129 of the prion protein increases its susceptibility to switch to the abnormal conformation, in comparison with the presence of valine at the same position.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749972     DOI: 10.1016/s0014-5793(01)03147-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Prion protein gene M129 allele is a risk factor for Alzheimer's disease.

Authors:  M Gacia; K Safranow; M Styczyńska; K Jakubowska; B Pepłońska; M Chodakowska-Zebrowska; I Przekop; A Słowik; E Golańska; K Hułas-Bigoszewska; D Chlubek; D Religa; C Zekanowski; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

Review 2.  The prion strain phenomenon: molecular basis and unprecedented features.

Authors:  Rodrigo Morales; Karim Abid; Claudio Soto
Journal:  Biochim Biophys Acta       Date:  2006-12-15

3.  Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.

Authors:  K S Satheeshkumar; R Jayakumar
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

4.  Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease.

Authors:  Marcin I Apostol; Michael R Sawaya; Duilio Cascio; David Eisenberg
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

5.  Selenomethionine incorporation into amyloid sequences regulates fibrillogenesis and toxicity.

Authors:  Javier Martínez; Silvia Lisa; Rosa Sánchez; Wioleta Kowalczyk; Esther Zurita; Meritxell Teixidó; Ernest Giralt; David Andreu; Jesús Avila; María Gasset
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

6.  Solvent microenvironments and copper binding alters the conformation and toxicity of a prion fragment.

Authors:  Mohammed Inayathullah; K S Satheeshkumar; Andrey V Malkovskiy; Antoine L Carre; Senthilkumar Sivanesan; Jasper O Hardesty; Jayakumar Rajadas
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.